Thor Medical ASA
(OSL:TRMED)
kr
2.47
-0.0050 (-0.2%)
Market Cap: 864.11 Mil
Enterprise Value: 742.03 Mil
PE Ratio: 0
PB Ratio: 2.07
GF Score: 27/100 Q2 2019 Nordic Nanovector ASA Earnings Presentation Transcript
Aug 22, 2019 / 06:30AM GMT
Release Date Price:
kr31.02
(-7.62%)
Eduardo Bravo
Nordic Nanovector ASA - CEO
Okay. Good morning. Thank you for coming this morning. I think that most of you know me, but I'm Eduardo Bravo. I'm the CEO of Nordic Nanovector, and together with some of the management team members, we have Lisa, Tone, Marco and Malene that will join me at the end for the Q&A session, as we've done at the last quarterly results.
I'm going to take you through the highlights of our second quarter report for the year 2019. And again, this is a big disclaimer that we're going to be making forward-looking statements.
So one
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
